Restricted accessResearch articleFirst published online 2024-03
Unpacking Immune Modulation as a Site of Therapeutics Innovation for Nematode Parasite Wuchereria bancrofti : A Temporal Quantitative Phosphoproteomics Profiling of Macrophage Migration Inhibitory Factor 2
Nematode infections are common in both humans and livestock, with major adverse planetary health and economic impacts. Wuchereria bancrofti is a parasitic nematode that causes lymphatic filariasis, a neglected tropical disease that can lead to severe disability and deformity worldwide. For the long-term survival of the bancroftian parasites in the host, a complex immune invasion strategy is involved through immunomodulation. Therefore, immunomodulation can serve as a site of research and innovation for molecular targets. Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine crucial to the host antimicrobial alarm system and stress response. Interestingly, the nematode parasite W. bancrofti also produces two homologs of MIF (Wba-MIF1 and 2). Using a mass spectrometry-based phosphoproteomics approach, we report new findings on the immunomodulatory effect and signaling mechanism of Wba-MIF2 in macrophage cells. Accordingly, we observed 1201 phosphorylated sites on 467 proteins. Out of the 1201 phosphorylated sites, 1075, 117, and 9 were found on serine (S), threonine (T), and tyrosine (Y) residues, respectively. Our bioinformatics analysis led to identification of major pathways, including spliceosomes, T cell receptor signaling pathway, Th17 differentiation pathway, interleukin-17 signaling pathway, and insulin signaling pathway upon Wba-MIF2 treatment. Wba-MIF2 treatment also enriched CDK4, CDK1, and DNAPK kinases. The comparison of the signaling pathway of Wba-MIF2 with that of human-MIF suggests both share similar signaling pathways. These findings collectively offer new insights into the role and mechanism of Wba-MIF2 as an immunomodulator and inform future diagnostics and drug discovery research for W. bancrofti.
Get full access to this article
View all access options for this article.
References
1.
AmdareNP, KhatriVK, YadavRSP, et al.Therapeutic potential of the immunomodulatory proteins Wuchereria bancrofti L2 and Brugia malayi abundant larval transcript 2 against streptozotocin-induced type 1 diabetes in mice. J Helminthol, 2017; 91(5):539–548; doi: 10.1017/S0022149X1600064X
2.
BerndsenCE, WolbergerC. New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol, 2014; 21(4):301–307; doi: 10.1038/nsmb.2780
3.
BilsborrowJB, DohertyE, TilstamPV, et al.Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Expert Opin Ther Targets, 2019; 23(9):733–744; doi: 10.1080/14728222.2019.1656718
4.
CalandraT, RogerT. Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol, 2003; 3(10):791–800; doi: 10.1038/nri1200
5.
ChauhanN, SharmaR, HotiSL. Identification and biochemical characterization of macrophage migration inhibitory factor-2 (MIF-2) homologue of human lymphatic filarial parasite, Wuchereria bancrofti. Acta Trop, 2015; 142:71–78; doi: 10.1016/j.actatropica.2014.10.009
6.
ChenA, KaganovskyE, RahimipourS, et al.Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: A putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res, 2002; 62(4):1036–1044
CooperPJ. Intestinal worms and human allergy. Parasite Immunol, 2004; 26(11–12):455–467; doi: 10.1111/j.0141-9838.2004.00728.x
9.
ElliottDE, UrbanJJ, ArgoCK, et al.Does the failure to acquire helminthic parasites predispose to Crohn's disease?. FASEB J, 2000; 14(12):1848–1855; doi: 10.1096/fj.99-0885hyp
10.
FalconeFH, PritchardDI. Parasite role reversal: Worms on trial. Trends Parasitol, 2005; 21(4):157–160; doi: 10.1016/j.pt.2005.02.002
11.
FigueiredoCA, BarretoML, RodriguesLC, et al.Chronic intestinal helminth infections are associated with immune hyporesponsiveness and induction of a regulatory network. Infect Immun, 2010; 78(7):3160–3167; doi: 10.1128/IAI.01228-09
12.
GnanaprakasamJN, WangR. MYC in Regulating immunity: Metabolism and beyond. Genes (Basel), 2017; 8(3):88; doi: 10.3390/genes8030088
13.
HaoNB, HeYF, LuoG, et al.Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: A meta-analysis. BMJ Open, 2013; 3(12):e003729; doi: 10.1136/bmjopen-2013-003729
14.
HarnettW. Secretory products of helminth parasites as immunomodulators. Mol Biochem Parasitol, 2014; 195(2):130–136; doi: 10.1016/j.molbiopara.2014.03.007
HoeraufA, SatoguinaJ, SaeftelM, et al.Immunomodulation by filarial nematodes. Parasite Immunol, 2005; 27(10–11):417–429; doi: 10.1111/j.1365-3024.2005.00792.x
17.
HubnerMP, StockerJT, MitreE. Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology, 2009; 127(4):512–522; doi: 10.1111/j.1365-2567.2008.02958.x
18.
JeongYE, RajbhandariL, KimBW, et al.Downregulation of SF3B2 protects CNS neurons in models of multiple sclerosis. Ann Clin Transl Neurol, 2023; 10(2):246–265; doi: 10.1002/acn3.51717
19.
HjæresenS, SejbaekT, AxelssonM, et al.MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple sclerosis. J Neurol Sci, 2022; 439:120320.
20.
KalalBS, ModiPK, NajarMA, et al.Hyperphosphorylation of HDAC2 promotes drug resistance in a novel dual drug resistant mouse melanoma cell line model: An in vitro study. Am J Cancer Res, 2021; 11(12):5881–5901.
21.
KarabowiczJ, DlugoszE, BaskaP, et al.Nematode orthologs of macrophage migration inhibitory factor (MIF) as modulators of the host immune response and potential therapeutic targets. Pathogens, 2022; 11(2):258; doi: 10.3390/pathogens11020258
22.
KarthikkeyanG, NajarMA, PervajeR, et al.Identification of molecular network associated with neuroprotective effects of yashtimadhu (Glycyrrhiza glabra L.) by quantitative proteomics of rotenone-induced Parkinson's sisease model. ACS Omega, 2020; 5(41):26611–26625; doi: 10.1021/acsomega.0c03420
23.
KaushalNA, HussainR, NashTE, et al.Identification and characterization of excretory-secretory products of Brugia malayi, adult filarial parasites. J Immunol, 1982; 129(1):338–343
24.
KudrinA, ScottM, MartinS, et al.Human macrophage migration inhibitory factor: A proven immunomodulatory cytokine?. J Biol Chem, 2006; 281(40):29641–29651; doi: 10.1074/jbc.M601103200
25.
La PortaJ, Matus-NicodemosR, Valentin-AcevedoA, et al.The RNA-binding protein, polypyrimidine tract-binding protein 1 (PTBP1) is a key regulator of CD4 T cell activation. PLoS One, 2016; 11(8):e0158708; doi: 10.1371/journal.pone.0158708
26.
LaphanuwatP, JirawatnotaiS. Immunomodulatory roles of cell cycle regulators. Front Cell Dev Biol, 2019; 7:23; doi: 10.3389/fcell.2019.00023
27.
LenkEJ, RedekopWK, LuyendijkM, et al.Productivity loss related to neglected tropical diseases eligible for preventive chemotherapy: A systematic literature review. PLOS Negl Trop Dis, 2016; 10(2):e0004397; doi: 10.1371/Journal.pntd.0004397
28.
LoureiroJ, PloeghHL. Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv Immunol, 2006; 92:225–305; doi: 10.1016/S0065-2776(06)92006-9
29.
MaizelsRM. Infections and allergy—Helminths, hygiene and host immune regulation. Curr Opin Immunol, 2005; 17(6):656–661; doi: 10.1016/j.coi.2005.09.001
30.
MathieuAL, VerroneseE, RiceGI, et al.PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity. J Allergy Clin Immunol, 2015; 135(6):1578–1588 e1575; doi: 10.1016/j.jaci.2015.01.040
31.
MorenoY, GearyTG. Stage- and gender-specific proteomic analysis of Brugia malayi excretory-secretory products. PLoS Negl Trop Dis, 2008; 2(10):e326; doi: 10.1371/journal.pntd.0000326
32.
MukherjeeS, KarnamA, DasM, et al.Wuchereria bancrofti filaria activates human dendritic cells and polarizes T helper 1 and regulatory T cells via toll-like receptor 4. Commun Biol, 2019; 2:169; doi: 10.1038/s42003-019-0392-8
33.
NajarMA, AravindA, DagamajaluS, et al.Hyperactivation of MEK/ERK pathway by Ca(2+)/calmodulin-dependent protein kinase kinase 2 promotes cellular proliferation by activating cyclin-dependent kinases and minichromosome maintenance protein in gastric cancer cells. Mol Carcinog, 2021a;60(11):769–783; doi: 10.1002/mc.23343
34.
NajarMA, ModiPK, RameshP, et al.Molecular profiling associated with calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2)-mediated carcinogenesis in gastric cancer. J Proteome Res, 2021b;20(5):2687–2703; doi: 10.1021/acs.jproteome.1c00008
35.
PailyKP, HotiSL, DasPK. A review of the complexity of biology of lymphatic filarial parasites. J Parasit Dis, 2009; 33(1–2):3–12; doi: 10.1007/s12639-009-0005-4
36.
Perez-RiverolY, BaiJ, BandlaC, et al.The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res, 2022; 50(D1):D543–D552; doi: 10.1093/nar/gkab1038
RexDAB, PatilAH, ModiPK, et al.Dissecting plasmodium yoelii pathobiology: Proteomic approaches for decoding novel translational and post-translational modifications. ACS Omega, 2022a;7(10):8246–8257; doi: 10.1021/acsomega.1c03892
39.
RexDAB, SubbannayyaY, ModiPK, et al.Temporal quantitative phosphoproteomics profiling of interleukin-33 signaling network reveals unique modulators of monocyte activation. Cells, 2022b;11(1):138; doi: 10.3390/cells11010138
40.
Sanchez-ZamoraYI, Rodriguez-SosaM. The role of MIF in type 1 and type 2 diabetes mellitus. J Diabetes Res, 2014; 2014:804519; doi: 10.1155/2014/804519
41.
SaundersKA, RaineT, CookeA, et al.Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun, 2007; 75(1):397–407; doi: 10.1128/IAI.00664-06
42.
SelvanLD, RenuseS, KaviyilJE, et al.Phosphoproteome of Cryptococcus neoformans. J Proteomics, 2014; 97:287–295; doi: 10.1016/j.jprot.2013.06.029
43.
ShaikhSB, NajarMA, PrabhuA, et al.The unique molecular targets associated antioxidant and antifibrotic activity of curcumin in in vitro model of acute lung injury: A proteomic approach. Biofactors, 2021; 47(4):627–644; doi: 10.1002/biof.1732
44.
SharmaR, HotiSL, MeenaRL, et al.Molecular and functional characterization of macrophage migration inhibitory factor (MIF) homolog of human from lymphatic filarial parasite Wuchereria bancrofti. Parasitol Res, 2012; 111(5):2035–2047; doi: 10.1007/s00436-012-3051-2
45.
SinghA, ChoudhurySD, SinghP, et al.Disruption in networking of KCMF1 linked ubiquitin ligase impairs autophagy in CD8(+) memory T cells of patients with renal cell carcinoma. Cancer Lett, 2023; 564:216194; doi: 10.1016/j.canlet.2023.216194
46.
SinghI, HotiSL, ChauhanN, et al.Immunomodulation of streptozotocin induced Type 1 diabetes mellitus in mouse model by macrophage migration inhibitory factor-2 (MIF-2) homologue of human lymphatic filarial parasite, Wuchereria bancrofti. Acta Trop, 2024 Feb. 7;252:107142; doi: 10.1016/j.actatropica.2024.107142. Epub ahead of print, PMID:38331083
47.
Stosic-GrujicicS, StojanovicI, Maksimovic-IvanicD, et al.Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J Cell Physiol, 2008; 215(3):665–675; doi: 10.1002/jcp.21346
Trivedi-ParmarV, JorgensenWL. Advances and insights for small molecule inhibition of macrophage migration inhibitory factor. J Med Chem, 2018; 61(18):8104–8119; doi: 10.1021/acs.jmedchem.8b00589
50.
van RietE, HartgersFC, YazdanbakhshM. Chronic helminth infections induce immunomodulation: Consequences and mechanisms. Immunobiology, 2007; 212(6):475–490; doi: 10.1016/j.imbio.2007.03.009
51.
VermaR, PintoSM, PatilAH, et al.Quantitative proteomic and phosphoproteomic analysis of H37Ra and H37Rv strains of Mycobacterium tuberculosis. J Proteome Res, 2017; 16(4):1632–1645; doi: 10.1021/acs.jproteome.6b00983
52.
WenAY, SakamotoKM, MillerLS. The role of the transcription factor CREB in immune function. J Immunol, 2010; 185(11):6413–6419; doi: 10.4049/jimmunol.1001829
53.
WHO. WHO GPELF Progress Report 2000–2009 and Strategic Plan 2010–2020. In: Control of Neglected Tropical Diseases (NTD). (IchimoriDK, ed.) World Health Organization; 2010; pp. 93.
54.
WHO. Global Programme to Eliminate Lymphatic Filariasis: Progress Report, 2019. Weekly Epidemiol Record, 2020; 43(95):25.
55.
YuT, LiYJ, BianAH, et al.The regulatory role of activating transcription factor 2 in inflammation. Mediators Inflamm, 2014; 2014:950472; doi: 10.1155/2014/950472
56.
VersiniM, JeandelPY, BashiT, et al.Unraveling the hygiene hypothesis of helminthes and autoimmunity: Origins, pathophysiology, and clinical applications. BMC Med, 2015; 13:81; doi: 10.1186/s12916-015-0306-7
57.
ZeidenrykLM, GreyM, SpeareR, et al.The emerging story of disability associated with lymphatic filariasis: A critical review. PLOS Negl Trop Dis, 2011; 5(12):e1366; doi: 10.1371/Journal.pntd.0001366
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
